Glaxo Group Ltd. v. Teva Pharmaceuticals USA, Inc.
1:17-cv-00357
Overview
Parties
Defendant
Teva Pharmaceuticals USA, Inc. Operating Company
Represented By
2 Attorneys ListedShaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Shaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Plaintiff
Glaxo Group Ltd. Operating Company
Represented By
2 Attorneys ListedFish & Richardson, P.C.
12390 El Camino Real, San Diego, CA 92130
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 7,500,444 Asserted | Asserted Patent | View Official Patent → |
| πΊπΈ United States | US 7,832,351 B2 | US Continuation / Sibling | View Official Patent → |
| π¬π§ United Kingdom | GB 0214360 A | United Kingdom Counterpart | View Official Patent → |
| π¬π§ United Kingdom | GB 0311191 A | United Kingdom Counterpart | View Official Patent → |
| π PCT International (WIPO) | WO 2004001664 A1 | PCT World Application | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7500444
Actuation indicator for a dispensing device
|
Filed: 2003-06-19
Issued: 2009-03-10
|
Expired (Term Ended)
+983d PTA
Expires: 2026-02-26
|
|
|
US7832351
Actuation indicator for a dispensing device
|
Filed: 2008-12-12
Issued: 2010-11-16
|
Active (2.1 yrs remaining)
Expires: 2028-12-12
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
High PTA (+983 days) / Cellect Scrutiny β Over 983 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
4
Dispositive
0
Granted
0
Denied
0
Pending / Review
2
Motions by Category
Key Dispositive Motions & Rulings